S. T. Vu

Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial

Hung N. Pham, K. D. Nguyen, Q. Pham, 2022, The Lancet Regional Health - Western Pacific.

Safety and Immunogenicity of Nanocovax, a SARS-CoV-2 Recombinant Spike Protein Vaccine

Hung N. Pham, K. D. Nguyen, T. V. Nguyen, 2021, medRxiv.

Fast and Sensitive Real-Time PCR Detection of Major Antiviral-Drug Resistance Mutations in Chronic Hepatitis B Patients by Use of a Predesigned Panel of Locked-Nucleic-Acid TaqMan Probes

A. Nguyen, H. M. Nguyen, Thuy T B Phung, 2021, Journal of clinical microbiology.

COLD-PCR Method for Early Detection of Antiviral Drug-Resistance Mutations in Treatment-Naive Children with Chronic Hepatitis B

H. Pham, A. Nguyen, H. M. Nguyen, 2020, Diagnostics.

The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial.

T. Nguyen, D. Anh, L. T. Phan, 2022, medRxiv.